GeneCentric Therapeutics, Inc. — Form D

GeneCentric Therapeutics, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2017-01-05. The offering totals $8.6M, of which $6.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
David Neil HayesDirectorDurham, NC
Arnold Neil LevineDirectorDurham, NC
Charles Neil PerouDirectorDurham, NC
Clay Neil ThorpDirectorDurham, NC
David Neil HayesExecutive OfficerDurham, NC
Clay ThorpDirectorDurham, NC
Ellen LubmanDirectorMorristown, NJ
MICHAEL MILBURNDirectorDurham, NC
MICHAEL MILBURNExecutive OfficerDurham, NC
ARNOLD LEVINEDirectorDurham, NC
CHARLES PEROUDirectorDurham, NC
CHARLES PEROUExecutive OfficerDurham, NC
Prasanth ReddyDirectorDurham, NC
MYLA LAI-GOLDMANDirectorDurham, NC
MYLA LAI-GOLDMANExecutive OfficerDurham, NC
Don HardisonDirectorDurham, NC
Ellen V LubmanDirectorDurham, NC
Michael V MilburnDirectorDurham, NC
Michael V MilburnExecutive OfficerDurham, NC
Perou V CharlesDirectorDurham, NC
Perou V CharlesExecutive OfficerDurham, NC
Clay V ThorpDirectorDurham, NC
Myla V Lai-GoldmanDirectorDurham, NC
Myla V Lai-GoldmanExecutive OfficerDurham, NC
Arnold V LevineDirectorDurham, NC

Other filings by this issuer (7)

FiledFormOfferingSold
2025-06-20D$5.0M$2.0M
2022-09-20D$3.5M$2.5M
2021-10-07D$7.5M$4.5M
2021-01-13D$1.2M$1.2M
2014-07-11D/A$5.0M$5.0M
2013-07-02D$5.0M$2.5M
2011-09-16D$250K$250K

More